FisherVista

Dr. Robert Whitfield introduces a BII health program pairing explant surgery with fat transfer, supported by clinical safety research, as part of a broader health optimization initiative called the SHARP Method.

Earth Science Tech, Inc. (OTC: ETST) CEO Giorgio R. Saumat will present at the Planet MicroCap Las Vegas 2026 Investor Conference, highlighting the company's vertically integrated healthcare platform.

A peer-reviewed study in JACC: Advances shows that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in patients with chest pain, achieving up to 92.9% accuracy with a baseline ECG.

BridgeCore Capital financed a McDonald's property in Saraland, Alabama, with a $1.4 million loan at 92% of purchase price, closing within 15 business days to meet the borrower's expedited timeline.

Dental implants remain the gold standard for tooth replacement, but costs can be daunting; this guide explains pricing factors, hidden fees, and strategies to save money without sacrificing quality.

Oncotelic Therapeutics and Sapu Nano have expanded their Phase 1b clinical program for Sapu003, appointing Global Clinical Trials as the lead CRO for international execution, marking a shift from an Australia-based study to a multinational development strategy.

Canamera Energy Metals Corp. accelerates exploration at its Brazilian rare earth projects and files a technical report, positioning itself in the critical minerals sector as demand surges due to the energy transition.

Trident Digital Tech Holdings Ltd. announced the launch of TDTHAI, an AI platform for enterprise deployment and digital transformation in Asia-Pacific, marking a key step in its strategy to build integrated digital infrastructure across emerging markets.

The Vaudreuil-Dorion Municipal Hub received the highest OAQ award for its design using Advanced Glazings’ SoleraWall System, emphasizing the importance of natural daylight in public architecture.

LIXTE Biotechnology Holdings announced a $16.6 million registered direct offering with accredited investors, using proceeds for general corporate purposes and strategic initiatives, positioning the company for its next growth phase.

TransCode Therapeutics announced Phase 1a results for TTX-MC138 showing no dose-limiting toxicities and durable disease stabilization in advanced cancer patients, supporting advancement to Phase 2a.

A new pill, daraxonrasib from Revolution Medicines, targets the KRAS gene and has reportedly doubled survival in early trials for pancreatic cancer, a disease that has long resisted treatment.

Rail Vision Ltd. announced its AI-powered ShuntingYard system has been integrated into Railserve’s YardGUARD safety system, enhancing real-time obstacle detection and automatic braking support in industrial railyards.

Biotech companies are increasingly focusing on drug-delivery platforms to enhance existing cancer therapies, with the market projected to reach $410 billion, highlighting a strategic shift from new drug discovery to optimizing delivery methods.

Gold prices gained on Tuesday due to easing U.S. Treasury yields and de-escalation in the Israel-Hezbollah conflict, with traders watching for a potential reclaim of the $5,000 mark.

As AI data centers' electricity demand is projected to double by 2030, companies like MAX Power Mining are advancing natural hydrogen as a potential off-grid power source, with the company confirming North America's first subsurface natural hydrogen system.

Ferrari's announcement of its first fully electric vehicle, the Luce, has sparked significant pushback from investors and enthusiasts, highlighting concerns over the brand's shift from its traditional combustion-engine heritage.

Onco-Innovations Limited announced the successful production of 952 grams of B4 precursor material for its ONC010 PNKP inhibitor, advancing toward clinical studies and scalable GMP manufacturing.

Oncotelic Therapeutics is featured in a BioMedWire editorial discussing how biotech companies leverage advanced drug-delivery technologies, nanotechnology, and AI to enhance therapies, with implications for scalable platforms in oncology and rare diseases.

Earth Science Tech Inc. (OTC: ETST) has repurchased 3.7 million shares over nine months, signaling a focus on shareholder value as it grows its telemedicine, pharmacy, and healthcare fulfillment businesses.